MedAvail To Report 2022 Third Quarter Financial Results on November 10, 2022
October 27 2022 - 4:05PM
Business Wire
MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a
technology-enabled pharmacy company, today announced it will report
financial results for the third quarter of 2022 on Thursday,
November 10, 2022, after market close. MedAvail management will be
webcasting a corresponding conference call beginning at 1:30 p.m.
Pacific Time / 4:30 p.m. Eastern Time.
The conference call can be accessed by registering online for
the live audio webcast on the “Investor Relations” section of
MedAvail’s website at: https://investors.medavail.com. The webcast
will be archived and available for replay after the event.
About MedAvail
MedAvail Holdings, Inc. (NASDAQ: MDVL) is a technology-enabled
pharmacy organization, providing turnkey in-clinic pharmacy
services through its proprietary robotic dispensing platform, the
MedAvail MedCenter, and home delivery operations, to Medicare
clinics. MedAvail helps patients to optimize drug adherence,
resulting in better health outcomes. Learn more at
www.medavail.com.
About SpotRx
SpotRx places control of the pharmacy experience back in the
hands of consumers. SpotRx is a telehealth platform that delivers
remote pharmacist consultations through an on-site dispensing
kiosk, supplemented with home delivery capability.
SOURCE MedAvail Holdings, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221027005313/en/
Investor Relations Ji-Yon Yi Gilmartin Group
ir@medavail.com
MedAvail (NASDAQ:MDVL)
Historical Stock Chart
From Jun 2024 to Jul 2024
MedAvail (NASDAQ:MDVL)
Historical Stock Chart
From Jul 2023 to Jul 2024